|Bid||2.80 x 800|
|Ask||33.00 x 2200|
|Day's range||27.15 - 28.93|
|52-week range||15.37 - 57.20|
|Beta (5Y monthly)||2.75|
|PE ratio (TTM)||N/A|
|Earnings date||28 Mar 2022 - 01 Apr 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||65.17|
Investors need to pay close attention to Celldex (CLDX) stock based on the movements in the options market lately.
We can readily understand why investors are attracted to unprofitable companies. For example, Celldex Therapeutics...
Celldex (CLDX) delivered earnings and revenue surprises of -11.43% and -91.02%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?